サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1790346

米国の細胞培養培地・細胞株の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、セグメント別予測、2025年～2033年

U.S. Cell Culture Media & Cell Lines Market Size, Share & Trends Analysis Report By Product (Traditional Cell Line, Classical Media), By Application (Biopharmaceutical Production, Diagnostics), By End Use, And Segment Forecasts, 2025 - 2033

出版日
ページ情報
英文 90 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.73円
米国の細胞培養培地・細胞株の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、セグメント別予測、2025年～2033年
出版日: 2025年07月21日
発行: Grand View Research
ページ情報: 英文 90 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場規模と動向

米国の細胞培養培地・細胞株市場規模は、2024年に19億7,000万米ドルとなり、2033年には43億6,000万米ドルに達すると予測され、2025～2033年のCAGRは9.45%で成長します。

この成長は、バイオ医薬品製造の需要増加、再生医療の進歩、研究開発活動への投資増加によってもたらされます。さらに、創薬や個別化医療における細胞培養技術の応用拡大が、予測期間中の市場拡大に拍車をかけると考えられます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の細胞培養培地・細胞株市場の変数と動向

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助的な市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 米国の細胞培養培地・細胞株市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 米国の細胞培養培地・細胞株市場：製品別、推定・動向分析

  • 製品セグメントダッシュボード
  • 米国の細胞培養培地・細胞株市場の製品変動分析
  • 米国の細胞培養培地・細胞株市場規模と動向分析（製品別、2021～2033年）
  • 従来型細胞株
    • 市場規模と動向分析（製品別、2021～2033年）
  • 従来培地
    • 市場規模と動向分析（製品別、2021～2033年）
  • 幹細胞と血液由来細胞
    • 市場規模と動向分析（製品別、2021～2033年）
  • 専用培地製品
    • 市場規模と動向分析（製品別、2021～2033年）

第5章 米国の細胞培養培地・細胞株市場：用途別、推定・動向分析

  • 用途セグメントダッシュボード
  • 米国の細胞培養培地・細胞株市場の用途変動分析
  • 米国の細胞培養培地・細胞株市場規模と動向分析（用途別、2021～2033年）
  • バイオ医薬品製造
  • 診断
  • 薬剤スクリーニングと開発
  • 組織工学と再生医療
  • その他

第6章 米国の細胞培養培地・細胞株市場：最終用途別、推定・動向分析

  • 最終用途セグメントダッシュボード
  • 米国の細胞培養培地・細胞株市場の最終用途変動分析
  • 米国の細胞培養培地・細胞株市場規模と動向分析（最終用途別、2021～2033年）
  • 大手バイオ医薬品企業
  • 中小規模のバイオテクノロジー企業
  • 受託調査製造機関（CRO/CMO）
  • 研究・学術機関
  • 病院と診断ラボ
  • その他

第7章 競合情勢

  • 企業/競合の分類
  • 戦略マッピング
  • 企業市況分析、2024年
  • 企業プロファイル/上場企業
    • Sartorius AG
    • Danaher
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • FUJIFILM Corporation
    • Lonza
    • STEMCELL Technologies
    • PromoCell GmbH
    • ATCC
    • AllCells
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 U.S. cell culture media & cell lines Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 U.S. cell culture media & cell lines Market, By Application, 2021 - 2033 (USD Million)
  • Table 6 U.S. cell culture media & cell lines Market, By End use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 U.S. cell culture media & cell lines market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market research process
  • Fig. 7 Information procurement
  • Fig. 8 Primary research
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 U.S. cell culture media & cell lines market: Product outlook key takeaways
  • Fig. 13 U.S. cell culture media & cell lines market: Product movement analysis
  • Fig. 14 U.S. traditional cell lines market, 2021 - 2033 (USD Million)
  • Fig. 15 U.S. traditional cell lines market, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. classical media market, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. stem cells & blood-derived cells U.S. cell culture media & cell lines market, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. specialty media products U.S. cell culture media & cell lines market, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. cell culture media & cell lines market: Application outlook and key takeaways
  • Fig. 20 U.S. cell culture media & cell lines market: Application movement analysis
  • Fig. 21 U.S. biopharmaceutical production market, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. drug screening and development market, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. tissue engineering and regenerative medicine market, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. other market, 2021 - 2033 (USD Million)
  • Fig. 26 U.S. cell culture media & cell lines market: End use outlook and key takeaways
  • Fig. 27 U.S. cell culture media & cell lines market: End use movement analysis
  • Fig. 28 U.S. large biopharmaceutical companies market, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. small and mid-sized biotechnology companies market, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. contract research and manufacturing organizations (CROs/CMOs) market, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. research and academic institutes market, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. hospital and diagnostic laboratories market, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. other end use market, 2021 - 2033 (USD Million)
目次
Product Code: GVR-4-68040-680-4

Market Size & Trends:

The U.S. cell culture media & cell lines market size was valued at USD 1.97 billion in 2024 and is anticipated to reach USD 4.36 billion by 2033, growing at a CAGR of 9.45% from 2025 to 2033. This growth is driven by increasing demand for biopharmaceutical production, advancements in regenerative medicine, and rising investments in research and development activities. Moreover, the expanding application of cell culture technologies in drug discovery and personalized medicine will fuel market expansion further over the forecast period.

U.S. Cell Culture Media And Cell Lines Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For

this study, Grand View Research has segmented the U.S. cell culture media & cell lines market report on the basis of product, application, and end use.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Traditional Cell Lines
  • Classical Media
  • Stem Cells & Blood-derived Cells
  • Specialty Media Products
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceutical Production
  • Diagnostics
  • Drug Screening and Development
  • Tissue Engineering and Regenerative Medicine
  • Other Applications
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Large Biopharmaceutical Companies
  • Small and Mid-sized Biotechnology Companies
  • Contract Research and Manufacturing Organizations (CROs/CMOs)
  • Research and Academic Institutes
  • Hospitals and Diagnostic Laboratories
  • Other End Uses

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Cell Culture Media & Cell Lines Market Variables & Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Advancements in Regenerative Medicine
      • 3.2.1.2. Advancements in Technology and Data Analytics
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Cost of Specialized Media and Cell Lines
      • 3.2.2.2. Stringent Regulatory and Quality Requirements
  • 3.3. U.S. Cell Culture Media & Cell Lines Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Cell Culture Media & Cell Lines Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. U.S. Cell Culture Media & Cell Lines Market Product Movement Analysis
  • 4.3. U.S. Cell Culture Media & Cell Lines Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Traditional Cell Lines
    • 4.4.1. Traditional Cell Lines Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.5. Classical Media
    • 4.5.1. Classical Media Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.6. Stem Cells & Blood-derived Cells
    • 4.6.1. Stem Cells & Blood-derived Cells Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.7. Specialty Media Products
    • 4.7.1. Specialty Media Products Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)

Chapter 5. U.S. Cell Culture Media & Cell Lines Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. U.S. Cell Culture Media & Cell Lines Market Application Movement Analysis
  • 5.3. U.S. Cell Culture Media & Cell Lines Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Biopharmaceutical Production
    • 5.4.1. Biopharmaceutical Production market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Diagnostics
    • 5.5.1. Diagnostics market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Drug Screening and Development
    • 5.6.1. Drug Screening and Development market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Tissue Engineering and Regenerative Medicine
    • 5.7.1. Tissue Engineering and Regenerative Medicine market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.8. Other Applications
    • 5.8.1. Other Applications market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Cell Culture Media & Cell Lines Market: End use Estimates & Trend Analysis

  • 6.1. End use Segment Dashboard
  • 6.2. U.S. Cell Culture Media & Cell Lines Market End use Movement Analysis
  • 6.3. U.S. Cell Culture Media & Cell Lines Market Size & Trend Analysis, by End use, 2021 to 2033 (USD Million)
  • 6.4. Large Biopharmaceutical Companies
    • 6.4.1. Large Biopharmaceutical Companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Small and Mid-sized Biotechnology Companies
    • 6.5.1. Small and Mid-sized Biotechnology Companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Contract Research and Manufacturing Organizations (CROs/CMOs)
    • 6.6.1. Contract Research and Manufacturing Organizations (CROs/CMOs) market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Research and Academic Institutes
    • 6.7.1. Research and Academic Institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8. Hospitals and Diagnostic Laboratories
    • 6.8.1. Hospitals and Diagnostic Laboratories market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9. Other End Uses
    • 6.9.1. Other End Uses market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Sartorius AG
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Danaher
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Merck KGaA
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Thermo Fisher Scientific, Inc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. FUJIFILM Corporation
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Lonza
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. STEMCELL Technologies
      • 7.4.7.1. Company overview
      • 7.4.7.2. Product benchmarking
      • 7.4.7.3. Strategic initiatives
    • 7.4.8. PromoCell GmbH
      • 7.4.8.1. Company overview
      • 7.4.8.2. Product benchmarking
      • 7.4.8.3. Strategic initiatives
    • 7.4.9. ATCC
      • 7.4.9.1. Company overview
      • 7.4.9.2. Product benchmarking
      • 7.4.9.3. Strategic initiatives
    • 7.4.10. AllCells.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Product benchmarking
      • 7.4.10.3. Strategic initiatives